Coherus works with Mark Cuban to sell biosimilar Humira at steep discount
In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling
Read MoreIn a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling
Read MoreDemocratic presidential candidate Robert F. Kennedy, Jr. lashed out at former President Donald Trump Tuesday, blasting him over what appears
Read MoreRepublican South Carolina Sen. Tim Scott said he envisions a future “where new medical cures and cheaper drugs are lowering
Read MoreNEWARK, Del, May 30, 2023 (GLOBE NEWSWIRE) — In the upcoming years, the blister packaging market is expected to expand
Read MoreThe in-home (outpatient) nurses are particularly trained in R327 DFI treatment protocols under the Australian guidelines. Credit: Darko Stojanovic from
Read MoreA visitor looks at the introduction of medicines for vaccines and chronic diseases at the Sanofi booth at the 5th
Read MoreSolskin Investment Thesis Demand for healthcare is relatively inelastic, which means that in case of a recession, Medios AG (OTCPK:MEDOF)
Read MoreBEIJING, May 28 (Reuters) – China’s market regulator said on Sunday it had fined two pharmaceutical companies for monopolistic behaviour.
Read MoreNew Delhi: Minister for health and chemicals & fertilizers Mansukh Mandaviya on Saturday advocated for a renewed emphasis on quality,
Read MoreSun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular
Read More